In Vivo Interaction Study
Increased systemic exposure was detected.
- CYP2D6 4173631
|Sample||Compound measured||Measurement||Value||Study sequence||Additional information||N replicates|
Probe cocktail study
CYP2D6 ultra-rapid metabolizer
(6 females) (age, mean ± SD = 24 ± 3.0 years; weight, 69.3 ± 14.2 kg)
Drug or Natural Product Administration
twice in 28 day trial
three times daily
Wild Oats Markets, Inc. Boulder, CO.
Pharmacodynamics (PD) & Adverse Events
General disorders and administration site conditions 35800000
Headache (4 of 12 subjects) and nausea (3 of 12 subjects)